Spun out of George Church's lab, this biotech upstart is mapping the AAV universe for Novartis, Sarepta to gaze

Press
May 11, 2020
Endpoints News
TOC LINK
TOC LINK
Press
Published 
May 11, 2020

More like this

Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy

Events
April 28, 2025

Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy

Events
April 28, 2025

Low-N OpenFold fine-tuning improves peptide design without additional structures

Publications
NeurIPS MLSB
October 4, 2024

Low-N OpenFold fine-tuning improves peptide design without additional structures

Publications
NeurIPS MLSB
October 4, 2024

Generative design for gene therapy: An in vivo validated method

Publications
NeurIPS GenBio
October 27, 2023

Generative design for gene therapy: An in vivo validated method

Publications
NeurIPS GenBio
October 27, 2023

Challenges and opportunities of machine-guided capsid engineering for gene therapy

Publications
Cell & Gene Therapy Insights
February 26, 2019

Challenges and opportunities of machine-guided capsid engineering for gene therapy

Publications
Cell & Gene Therapy Insights
February 26, 2019
™
343 Arsenal St
Watertown, MA 02472
© Dyno 2024
Privacy PolicyTerms + Conditions